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Tumorigenesisis required for the self-renewal of stem cells from diverse tissues, including the
central nervous system (CNS). Bmi-1 expression is elevated in most human gliomas, irrespective of grade,
raising the question of whether Bmi-1 over-expression is sufﬁcient to promote self-renewal or tumorigenesis
by CNS stem/progenitor cells. To test this we generated Nestin-Bmi-1-GFP transgenic mice. Analysis of two
independent lines with expression in the fetal and adult CNS demonstrated that transgenic neural stem cells
formed larger colonies, more self-renewing divisions, and more neurons in culture. However, in vivo, Bmi-1
over-expression had little effect on CNS stem cell frequency, subventricular zone proliferation, olfactory bulb
neurogenesis, or neurogenesis/gliogenesis during development. Bmi-1 transgenic mice were born with
enlarged lateral ventricles and a minority developed idiopathic hydrocephalus as adults, but none of the
transgenic mice formed detectable CNS tumors, even when aged. The more pronounced effects of Bmi-1
over-expression in culture were largely attributable to the attenuated induction of p16Ink4a and p19Arf in
culture, proteins that are generally not expressed by neural stem/progenitor cells in young mice in vivo. Bmi-
1 over-expression therefore has more pronounced effects in culture and does not appear to be sufﬁcient to
induce tumorigenesis in vivo.
© 2009 Elsevier Inc. All rights reserved.Introduction
Bmi-1 is a polycomb group protein that functions as one component
of the repressor complex 1 to modify histones, regulating chromatin
structure and repressing transcription (Valk-Lingbeek et al., 2004).
Bmi-1 is required for the postnatal self-renewal of stem cells from
diverse tissues including the hematopoietic system (Lessard and
Sauvageau, 2003; Park et al., 2003) and the CNS (Bruggeman et al.,
2005; Molofsky et al., 2003, 2005). Bmi-1 deﬁcient mice exhibit a
progressive postnatal depletion of stemcells from these tissues, leading
to hematopoietic failure, defects in cerebellum development, neurolo-
gical abnormalities, and death by early adulthood (Leung et al., 2004;
van der Lugt et al., 1994). Bmi-1 promotes the self-renewal of neural
stemcells and other stemcells largely, but not exclusively, by repressing
the expression of Ink4a and Arf (Bruggeman et al., 2005; Jacobs et al.,
1999; Molofsky et al., 2003, 2005). Ink4a and Arf encode the p16Ink4aamamatsu University School of
Shizuoka 431-3192, Japan.
Porter Psychiatric Institute, San
l rights reserved.and p19Arf tumor suppressor proteins that inhibit cell cycle progression
and induce cellular senescence (Lowe and Sherr, 2003). Bmi-1 thus
promotes the maintenance of CNS stem cells throughout adult life by
repressing tumor suppressors associated with cellular senescence.
Bmi-1 was originally identiﬁed as a transgene that could co-
operate with myc to induce hematopoietic malignancies (Haupt et al.,
1993; Jacobs et al., 1999; van Lohuizen et al., 1991). Elevated Bmi-1
expression has been observed in hematopoietic malignancies (Bea et
al., 2001), medulloblastomas and gliomas (Bruggeman et al., 2007;
Leung et al., 2004), and cancers from other tissues (Song et al., 2006;
Tateishi et al., 2006; Vonlanthen et al., 2001; Wang et al., 2008).
Indeed, Bmi-1 is necessary for the maintenance of cancer stem cells
from acute myeloid leukemias (Lessard and Sauvageau, 2003) as well
as gliomas (Bruggeman et al., 2007). Bmi-1 is thus necessary for the
progression of certain types of cancer and increased Bmi-1 expression
may contribute to tumorigenesis in certain contexts.
These observations raise the question of whether over-expression
of Bmi-1 in neural stem/progenitor cells is sufﬁcient to enhance the
self-renewal of these cells or to render them tumorigenic. Retroviral
over-expression of Bmi-1 can increase hematopoietic stem cell self-
renewal in culture and enhance the ability of these cells to
reconstitute irradiated mice (Iwama et al., 2004). However, it is
important to distinguish between the effects of Bmi-1 in culture and in
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in culture: Ink4a-Arf is rarely expressed by normal cells in fetal or
young adult mice in vivo but is induced in cultured cells as a stress
response to unphysiological conditions (Lowe and Sherr, 2003; Sherr
and DePinho, 2000). Consistent with this, Bmi-1 can be necessary for
maintaining stem cell self-renewal in culture in a way that is not
observed in vivo in certain contexts: fetal neural stem cells from Bmi-1
deﬁcient mice exhibit a self-renewal defect in culture but no
detectable defect in Bmi-1 deﬁcient mice in vivo (Molofsky et al.,
2003). Thus, as a result of increased Ink4a-Arf expression in culture,
Bmi-1 can sometimes exhibit functions in culture that are not
observed in vivo. Nonetheless, Bmi-1 also promotes stem cell self-
renewal and cancer cell proliferation through Ink4a-Arf-independent
mechanisms (Bruggeman et al., 2007; Chagraoui et al., 2006).
Resolving the question of whether Bmi-1 over-expression is sufﬁcient
for tumorigenesis and increased stem cell self-renewal in vivo will be
critical to determine whether elevated Bmi-1 expression can be an
initiating event in the etiology of brain tumors.
We examined Bmi-1 expression in both high-grade and low-grade
human gliomas as well as in normal CNS tissue. Consistent with a
recent report (Bruggeman et al., 2007), we observed elevated Bmi-1
expression in most high grade and low grade gliomas. To test whether
Bmi-1 over-expression is sufﬁcient to promote self-renewal and
tumorigenesis by stem/progenitor cells in the CNS, we generated
Nestin-Bmi-1-GFP transgenic mice that expressed Bmi-1 throughout
CNS stem and progenitor cells. While Bmi-1 over-expression was
sufﬁcient to increase self-renewal, overall proliferation, and neuronal
differentiation by CNS stem and progenitor cells in culture, little
change in neural stem/progenitor cell function, neurogenesis or
gliogenesis was observed in vivo. A minority of the transgenic mice
developed idiopathic hydrocephalus and died early in adulthood, but
none of the transgenic mice developed CNS tumors at any develop-
mental stage up to and including two years of age. These results
indicate that the consequences of Bmi-1 over-expression in stem/
progenitor cells are more dramatic in culture and that Bmi-1 over-
expression is not sufﬁcient to drive tumorigenesis by CNS stem/
progenitor cells in vivo.
Materials and methods
Generation of Nestin-Bmi-1-HA-GFP transgenic mice
Full-length mouse Bmi-1 cDNA was PCR ampliﬁed from total
mouse embryo cDNA and HA-tagged, then inserted into the pMIG
vector immediately upstream of the IRES site. The Bmi-1-IRES-GFP
fragment was then isolated by NotI digestion and inserted into NotI
digested nes1852tk/lacZ plasmid (kindly provided by Dr. Urban
Lendahl). This nes1852tk/lacZ plasmid carried the Nestin second
intronic enhancer that has previously been shown to drive transgene
expression in CNS stem and progenitor cells (Kawaguchi et al., 2001)
as well as the thymidine kinase minimal promoter (Lothian and
Lendahl, 1997). The entire sequence (∼7600 bp) was then linearized
with ScaI and microinjected into mouse zygotes (Hogan et al., 1994).
Founder mice were bred to wild-type C57Bl/6 mice. Offspring were
screened by GFP phenotyping of the brain in neonatal pups, and by
genotyping using PCR at later ages using the primer set: 5′-
TGGACACAAAGACCTCGTG-3′ and 5′-GGTTGTTCGATGCATTTCTGC-3′.
Isolation of CNS progenitors and ﬂow cytometry analysis
Adult lateral ventricle subventricular zone (SVZ) cells from 2 to
4 month old wild type or transgenic mice were obtained by micro-
dissecting the lateral walls of the lateral ventricles, then dissociating
for 20 min at 37 °C in 0.025% trypsin/0.5 mM EDTA (Calbiochem; San
Diego, CA) plus 0.001% DNase1 (Roche; Indiannapolis, IN). After
quenching the enzymatic dissociation with staining medium (L15medium (Invitrogen; Carlsbad, CA) supplemented with 1 mg/ml BSA
(Sigma; St. Louis, MO), 10 mM HEPES (pH 7.4) and 1% penicillin/
streptomycin (Invitrogen)) containing 0.014% soybean trypsin inhi-
bitor (Sigma) and 0.001% DNase1, the cells were washed and
resuspended in staining medium, triturated, ﬁltered through nylon
screen (45 μm, Sefar America; Depew, NY), counted by haemocyt-
ometer, and plated.
For ﬂow-cytometric analysis of GFP expression in transgenic
mouse brain tissue, freshly dissociated single cell suspensions from
neonatal mouse cerebral cortex and cerebellum, or adult SVZ were
analyzed by a FACS VantageSE ﬂow-cytometer (Becton-Dickinson; San
Jose, CA). Dead cells were excluded from analysis by DAPI staining.
Neural stem cell culture, differentiation, cell proliferation and
self-renewal assays
For neurosphere culture, dissociated SVZ cells were plated at clonal
density (1.3 cells/μl of culture medium) onto ultra-low binding plates
(Corning, Lowell, MA). The culture medium (self-renewal medium)
was based on a 5:3 mixture of DMEM-low glucose: neurobasal
medium (Invitrogen) supplemented with 20 ng/ml human bFGF
(R&D Systems, Minneapolis, MN), 20 ng/ml EGF (R&D Systems), 1%
N2 supplement (Invitrogen), 2% B27 supplement (Invitrogen), 50 μM
2-mercaptoethanol (Sigma), 1% pen/strep (Invitrogen) and 10% chick
embryo extract (prepared as described (Stemple and Anderson,
1992)). All cultures were maintained at 37 °C in 6% CO2/balance air.
Neurosphere numbers and diameters were determined on the tenth
day of culture.
For neurosphere culture from single cells, P5 wild type and
transgenic mouse SVZ cells were dissociated as described above. To
enrich neural stem cells, the dissociated SVZ cells were stained with
anti-CD24 (BD Biosciences, San Jose, CA) and anti-CD15 (clone MMA)
antibodies, and single CD24−CD15hi cells were sorted into eachwell of
96 well ultra-low binding plates. Single cell sorting was conﬁrmed in
control plates stained with DAPI. Cultures were maintained at 37 °C in
6% CO2/balance air. Neurospheres were measured and subcloned for
self-renewal quantiﬁcation on the tenth day of culture.
To assess the differentiation of primary neurospheres, individual
neurospheres were replated onto poly-D-lysine (PDL, Biomedical
technology, Stoughton, MN) and ﬁbronectin (Biomedical technology)
coated 48-well plates and cultured adherently in differentiation
medium for 7 days before being ﬁxed and stained for markers of
neurons, oligodendrocytes, and astrocytes as previously described
(Molofsky et al., 2003). Differentiation medium was the same as self-
renewal medium except that it contained no EGF, and reduced
concentrations of chick embryo extract (1%) and FGF (10 ng/ml).
For cell proliferation assays, dissociated adult SVZ cells were plated
onto PDL and laminin (Invitrogen) coated tissue culture plates at
clonal density (0.7 cells/μl) and cultured for 6 days, thenpulse-labeled
with 10 μMBrdU for 1 h at 37 °C before being ﬁxed and stainedwith an
antibody against BrdU as described (Molofsky et al., 2003). Only stem
cell colonies (identiﬁed by large compact colony morphology) were
included in this analysis.
To assess the self-renewal potential of cultured neural stem cells,
individual primary neurospheres were mechanically dissociated by
trituration and then replated at clonal density (1.3 cells/μl) into non-
adherent cultures. Secondary neurospheres were counted 10 days
later and differentiated in the same manner as described above. Self-
renewal is reported as the number of multipotent secondary neuro-
spheres that arose per subcloned primary neurosphere.
Generation of Bmi-1-GFP-MSCV virus and infection of neural stem cells
Bmi-1 bearing retrovirus was made using a mouse stem cell virus
(MSCV) vector (pMIG) which contains an internal ribosome entry site
(IRES) followed by GFP (Van Parijs et al.,1999). Full lengthmouse Bmi-
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cDNA. Hpa1 and Bgl2 sites were added to either end and the sequence
was inserted into the MSCV vector 5′ to the IRES GFP. Preparation of
high-titer virus was carried out by calcium phosphate transfection of
BOSC packaging cells (Pear et al., 1993) with the Bmi-MSCV vector.
Vesicular stomatitis virus G protein (VSV-G) plasmid was added
during transfection to increase the infectivity of the packaged virus
(Lee et al., 2001). Cells were allowed to produce virus for 24–48 h, then
cell supernatants were collected, 0.2 micron ﬁltered, and stored at
−80 °C or used fresh to infect cultured neural stem/progenitor cells.
Neonatal lateral ventricular zone (VZ) tissue from wild type or
Ink4a-Arf deﬁcient mice was dissected, dissociated, and cultured as
described above. Cells were plated adherently at high density (20,000
cells per well of a six-well plate). After 24–48 h of culture, viral
supernatant was added for 12–24 h. Then the culture medium was
replaced for 24–48 h, and cells were brieﬂy trypsinized and replated at
clonal density (0.7 cells/μl of media). Viral titers allowed infection of
25 to 90% of colonies.
Immunohistochemistry of tissue sections
Immunohistochemical staining of Bmi-1 on normal human brain
tissue and brain tumor samples was performed on the DAKO
Autostainer (DAKO, Carpinteria, CA) using DAKO Envision+ and
diaminobenzadine (DAB) as the chromogen. De-parafﬁnized sections
of formalin ﬁxed tissue at 5 μm thickness were labeled with mouse
monoclonal anti-Bmi-1 (1:400, Clone F6, Upstate Chemicals, Pickens,
SC) for 60 min, after microwave citric acid epitope retrieval.
Appropriate negative (no primary antibody) and positive controls
(high grade brain tumor) were stained in parallel with each set of
tumors studied. The immunoreactivity was scored by a three-tier
(negative, low (+) and high (++) positive) grading scheme.
For immunoﬂuorescence staining of mouse brain sections, whole
embryos or postnatal brains were ﬁxed in 4% paraformaldehyde
overnight, then cryoprotected in 30% sucrose, embedded in OCT
(Sakura Finetek, Torrance, CA) and ﬂash frozen. Twelve micron
sections were cut on a Leica cryostat and air dried over night. Tissue
sections were ﬁrst blocked in PG/HN (5% horse serum, 5% goat serum,
1% BSA, 0.05% sodium azide and 0.05% Triton X-100 in 1× PBS) for 1 h
at room temperature (RT). Primary antibodies were diluted in PG/HN
and incubated with the sections for 1 h at RT, followed by washing
then secondary antibody incubation for 1 h at RT. Antibodies included
mouse monoclonal anti-GFAP (1:500, Clone G-A-5, Sigma); mouse
monoclonal anti-b-III-Tubulin (1:500, Clone TUJ1, Covance); rat
monoclonal anti-myelin basic protein (MBP, 1:100, Millipore, Teme-
cula, CA), rabbit polyclonal anti-BFABP (1:2000, gift from T. Muller,
Max-Delbruck-Center, Berlin, Germany), mouse monoclonal anti-
Reelin (1:1000, Clone G10, Abcam), rabbit polyclonal anti-FoxP2
(1:500, Abcam) and Alexa 488 conjugated rabbit polyclonal anti-GFP
(1:400, Invitrogen). Alexa Fluor conjugated secondary antibodies
were purchased from Invitrogen and used at 1:500 dilution. Nuclei
were visualized using DAPI (2 μg/ml, Sigma) and slides weremounted
with Prolong antifade solution (Invitrogen). Images were collected on
a Leica TCS SP5 laser scanning confocalmicroscope, andmulti-channel
overlays were assembled in Adobe Photoshop.
For immunohistochemical staining of Bmi-1 on E15 telencephalon,
12 μm frozen sections of E15 wild type and transgenic mouse
telencephalon were ﬁrst treated with 3% H2O2/0.1% NaN3 for 1 h at
RT to quench endogenous peroxidase activity, then blocked with PG/
HN before being labeled with mouse monoclonal anti-Bmi-1 (1:400,
Clone F6, Upstate Chemicals) for 60 min at room temperature. The
staining were then visualized using DAKO Envision+ and diamino-
benzadine (DAB) as the chromogen.
To quantify adult SVZ proliferation, mice were injected with
100 mg/kg of 5-bromo-2-deoxyuridine (BrdU, Sigma), and sacriﬁced
2 h later. Brains were ﬁxed and embedded as described above. Twelvemicron thick coronal sections were cut on a Leica cryostat. For
detection of BrdU, DNAwas ﬁrst denatured in 2 N HCl for 45 min at RT
and neutralized with 0.1 M Sodium Borate for 10 min. Sections were
then pre-blocked in PG/HN for 1 h at RT and stained with primary rat
anti-BrdU antibody (1:500, Accurate Chemical, Westbury, NY) diluted
in PG/HN for 1 h at room temperature, followed by biotinylated goat-
anti-rat IgG (Jackson Immunoresearch) for 30min at RT. BrdU staining
were then visualized with Alexa594-conjugated streptavidin (Invitro-
gen) and nuclei were counter-stainedwith DAPI. Slides weremounted
using ProLong antifade solution (Invitrogen) and imaged on a Leica
TCS SP5 laser scanning confocal microscope using a 63× oil immersion
objective (NA=1.4).
To assess proliferation in E14.5 telencephalon, timed pregnant
females were injected with a single dose of 100 mg/ml BrdU 15 min
prior to euthanization. Tissue processing and BrdU staining were then
performed in a similar manner as described for adult tissue.
To quantify olfactory bulb neurogenesis, 1–2 month old mice were
given a single injection of 100 mg/kg of BrdU and kept on BrdU-
containing drinking water (1 mg/ml) for the next 7 days. They were
switched to regular water for an additional 4 weeks before being
sacriﬁced. Brains were ﬁxed and embedded as described. Ten micron
coronal sections of the olfactory bulb were cut on a Leica cryostat.
Tissue sections were blocked with PG/HN, stained with anti-NeuN
(1:100, Clone A60, Millipore), re-ﬁxed with 4% PFA then stained for
BrdU as described above. NeuN staining was visualized with
Alexa555-conjugated goat-anti-mouse IgG1 secondary antibody (Invi-
trogen). BrdU staining was visualized with biotinylated goat-anti-rat
IgG secondary antibody and Alexa594 conjugated streptavidin. Nuclei
were counter-stained with DAPI. Slides were mounted in Prolong
antifade (Molecular Probes), and imaged on a Leica TCS SP5 laser
scanning confocal microscope using a 63× oil immersion objective
(NA=1.4). Twenty ﬁve random ﬁelds of view (each containing 300–
500 cells) spanning the full thickness of the olfactory bulb were
counted in ImageJ software.
Neuron birth dates were determined by injecting timed pregnant
females with a single dose of 100 mg/ml 5-chloro-2-deoxyuridine
(CldU, Sigma) at E17. Pups were sacriﬁced at P20, brains were ﬁxed
and embedded as described, and 40 μm-thick ﬂoating sections were
cut on a Leica cryostat. CldU staining was performed in a similar
manner as described for BrdU, using CldU-speciﬁc (1:500, Clone BU1/
75, Accurate Chemical) antibody (Kiel et al., 2007); Cux-1 was stained
using a rabbit polyclonal anti-Cux1 antibody (1:50, Santa Cruz
Biotechnology; Santa Cruz, CA). CldU staining was visualized by
biotinylated goat-anti-rat IgG secondary antibody and Alexa594
conjugated streptavidin, and Cux-1 staining was visualized using
Alexa555 conjugated goat-anti-rabbit IgG secondary antibody.
MRI analysis
All mice analyzed were anesthetized with 2% isoﬂurane/air mixture
throughout MRI. Mice lay prone, head ﬁrst in a 7.0 T VarianMR scanner
(183-mm horizontal bore, Varian, Palo Alto, CA), with the body
temperature maintained at 37 °C using circulated heated air. A double-
tuned volume radio frequency coil was used to scan the head region of
themice. Axial T2-weighted imageswere acquiredusing a fast spin-echo
sequence with the following parameters: repetition time (TR)/effective
echo time (TE), 4000/47.456 ms; ﬁeld of view (FOV), 30×30 mm;
matrix, 256×128; slice thickness, 0.5 mm; slice spacing, 0 mm; number
of slices, 25; and number of scans, 1 (total scan time ∼1 min).
Results
Bmi-1 expression is elevated in a subset of human CNS tumors
We examined the expression of Bmi-1 in normal and diseased
humanparenchymalbrain tissuebyperforming immunohistochemistry
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samples of normal brain tissue (Suppl. Fig. 1A). We did observe strong
Bmi-1 staining in the vastmajorityof cellswithin awhitematter biopsy
from a patient after an epileptic seizure (Suppl. Fig.1B). Bmi-1 staining
was also observed in most specimens from patients that exhibited
gliosis due to damage (mesial temporal lobe sclerosis) or abscess (4 of
5 specimens; Suppl. Fig.1C). These results demonstrate that Bmi-1 can
be upregulated, particularly in glia, after brain injuries.
Similar to what has been reported recently (Bruggeman et al.,
2007), we also observed elevated Bmi-1 expression in a subset of
human gliomas (Suppl. Figs. 1D–F). Strong Bmi-1 expression was
observed in most cells from 10 of 30 glioblastoma specimens (Suppl.
Fig. 1F), while 7 of 30 specimens exhibited detectable, but lower levels
of Bmi-1 expression in fewer cells. Variable levels of Bmi-1 expression
were detected in some cells in low grade gliomas (1 of 2 specimens,
data not shown), pilocytic astrocytomas (3 of 4 specimens; Suppl. Fig.
1D), and oligodendrogliomas (4 of 5 specimens; Suppl. Fig. 1E). These
data indicate that Bmi-1 expression is elevated in most human CNS
tumors, though no strong correlation between Bmi-1 expression level
and the type or grade of the tumors was observed (Suppl. Fig. 1H).
These data raise the question of whether elevated Bmi-1 expression is
sufﬁcient to drive tumorigenesis in CNS stem/progenitor cells.
Generation of Nestin-Bmi-1-GFP transgenic mice
To examine the effects of Bmi-1 over-expression on neural stem/
progenitor cell function and CNS tumorigenesis in vivo, we generated
transgenic mice in which the human Nestin second intron enhancer
was used to drive the expression of HA-tagged mouse Bmi-1 protein,
as well as a GFP reporter in CNS stem and progenitor cells (Fig. 1A).
Nestin is expressed in CNS stem and progenitor cells (Dahlstrand et
al.1992a,b; Kawaguchi et al., 2001), as well as in various CNS tumors
(Almqvist et al., 2002; Rutka et al., 1999). The human Nestin second
intron enhancer has been shown to drive transgene expression in
mouse CNS stem and progenitor cells during embryonic development
and adulthood (Lothian and Lendahl, 1997).
Ten of 77 (13%) pups born after zygote injection harbored the
Nestin-Bmi-1-GFP construct based on PCR genotyping of tail DNA as
well as by observation of GFP expression in the CNS (analyzed by
transillumination of the head). Although one transgenic pup died
shortly after birth of unknown causes, most of the transgenic offspring
appeared healthy and developed normally. Southern blotting was
performed on the surviving founders to conﬁrm transgene integration
and to determine copy number (Suppl. Fig. 2A). Five lines that gave
germ line transmission of the transgenewere successfully established.
One line (line B⁎) exhibited transgene segregation among F1 progeny
in a way that suggested the original founder had multiple transgene
integration sites (Suppl. Fig. 2B). As a result, two sub-lines from line B⁎
were established: line B that had up to ﬁve copies of the transgene in a
single integration site and line K that had more than 25 copies of the
transgene.
To select for lines that exhibited transgene expression in CNS stem/
progenitor cells throughout development and adulthood, we analyzed
GFP expression in neonatal and adult F1 transgenic mouse brains by
direct observation of GFP ﬂuorescence and by analysis of dissociated
cells fromvarious CNS regions usingﬂow-cytometry. Surprisingly, only
the two transgenic lines (lines B and C)with the lowest transgene copy
number (approximately 5 copies of the transgene inserted into a single
site in the genome) maintained GFP expression in both the newborn
and adult brain (Suppl. Fig. 3A). All other lines either showed no
transgene expression (lines D and K) at either stage, or showed only
weakGFP expression at birth thatwas no longer detectable in the adult
brain (lines E and G) (Suppl. Fig. 3A). Therefore, for our analysis of the
consequences of Bmi-1 over-expression in vivo we studied lines B and
C. The transgene was inherited with expected Mendelian frequencies
in these lines (Suppl. Fig. 4A).Characterization of transgene expression in vivo
GFP expression in the transgenic mouse CNS could be detected at
all developmental stages in patterns that resembled endogenous
Nestin expression (Lothian and Lendahl, 1997) in both lines B and C. At
embryonic day (E)14.5, GFP was ubiquitously expressed throughout
the developing CNS (Fig. 1B). In contrast, we did not observe GFP
ﬂuorescence in tissues outside of the nervous system or in littermate
controls (Fig. 1B). At birth (P0), GFP was still widely expressed in all
brain regions of transgenic mice but not littermate controls (Fig. 1C).
The highest levels of expression appeared to be in the ventricular
zones throughout the brain as well as in nerve ﬁber bundles within
the corpus callosum and anterior commissure (Fig. 1C). This wide-
spread transgene expression was also conﬁrmed by analyzing freshly
dissociated cells from various neonatal brain regions by ﬂow-
cytometry: most cells from the P0 transgenic lateral ventricle
germinal zone (VZ; 90±8%), cerebral cortex (88±9%), and cerebel-
lum (66±11%) expressed GFP (Fig. 1G).
In contrast, GFP expression in the adult transgenic brain became
more spatially restricted. Whole brain GFP ﬂuorescence was greatly
reduced as compared with E14.5 or P0 brain (Fig. 1D); and most of the
GFP expressing cells were localized to brain regions that contain
neural stem/progenitor cells, such as the SVZ of the lateral ventricle
(Fig. 1E) and the subgranular cell layer in the dentate gyrus of the
hippocampus (Fig. 1F). Brain layers that contained differentiated cells
showed no detectable GFP expression (Figs.1E, F). GFP expressionwas
also not observed in tissue lacking appreciable Nestin expression, such
as in adult bone marrow (Suppl. Fig. 3B). The enrichment of GFP
expressing cells in adult SVZ was further conﬁrmed by ﬂow-
cytometry, which showed that 76±9% of all dissociated SVZ cells
were GFP+ (Fig. 1H). GFP expression thus correlated with the
expected pattern of Nestin expression in stem/progenitor cells in
vivo, throughout development and into adulthood.
To directly conﬁrm that the transgene was indeed expressed by
neural stem and progenitor cells, GFP+ and GFP− cells from freshly
dissociated neonatal cerebral cortex, VZ, and cerebellum were sorted
into culture. The vast majority (N94%) of neurospheres arose from the
GFP+ fraction of cells while GFP− cells formed few or no neurospheres
(Fig. 1I). Upon differentiation, some of the GFP+ neurospheres formed
multilineage colonies (containing neurons, astrocytes and oligoden-
drocytes) while other GFP+ neurospheres formed colonies that
contained only astrocytes, or neurons and astrocytes. GFP− neuro-
spheres usually did not formmultilineage colonies. This indicates that
virtually all multipotent cells (N99%) expressed the transgene but that
GFP expressing cells were functionally heterogeneous and contained
both neural stem and progenitor cells.
The transgene was also expressed by neural stem/progenitor cells
from the brains of adult transgenic mice. SVZ cells were dissociated
from the brains of two to three month old transgenic mice and GFP+
or GFP− cells were sorted into culture. Over 97% of neurosphere-
forming cells were GFP+ and most of these neurospheres underwent
multilineage differentiation (Figs. 1J, K). Since GFP expression was
observed throughout the adult SVZ, and most adult SVZ cells are
restricted progenitors that fail to formmultipotent colonies in culture,
the data suggest that many restricted progenitors in the adult brain
also expressed the transgene. These data suggest that newborn and
adult mice exhibited transgene expression in neural stem cells as well
as in restricted neural progenitors.
The transgene increases Bmi-1 expression in neural stem cells
To assess the level of Bmi-1 over-expression as a result of transgene
expression, we performed quantitative (real-time) reverse transcrip-
tion polymerase chain reaction (qRT-PCR) and western blotting using
freshly isolated SVZ cells and cultured neurospheres. In cultured
neurospheres from adult SVZ, Bmi-1 transcript levels were 15-fold and
Fig. 1. Transgene expression in Nestin-Bmi-1-GFP transgenic mice. (A) Schematic representation of the Nestin-Bmi-1-GFP transgene. (B) GFP epiﬂuorescence shows transgene
expression throughout the CNS in an E14.5 transgenic embryo but not in non-neural tissues or in a wild type control embryo (to the left of the transgenic embryo). (C) The transgene
was still widely expressed in most regions of the P0 transgenic brain, with nerve ﬁber bundles (ac, cc) and the wall of the ventricular system (aq) expressing the highest levels of GFP
(left, whole brain overview; right, sagittal view from themidline). (D–F) GFP expression becamemore restricted in the adult transgenic mouse brain (D) and concentrated in regions
enriched for neural stem/progenitor cells, such as the SVZ of the lateral ventricle (E) and the subgranular layer of the dentate gyrus (F). All photos are from line C transgenic mice, but
are also representative of line Bmice. Flow-cytometry of cells from line Bmice conﬁrmed the presence of GFP+ cells in the ventricular zone, the cortex, and the cerebellum of neonatal
transgenic mice (green histograms; (G)) but not in control littermates (unshaded histograms; (G)), as well as in the adult SVZ (H). (I–J). The vast majority of neurospheres formed by
neonatal VZ, cerebral cortex, and cerebellum (I) as well as adult SVZ (J) derived from the GFP+ fraction of cells. Data represent mean±s.d. from 3 independent experiments using
line B transgenic mice. (K) Many Bmi-1 transgenic neurospheres were capable of undergoing multilineage differentiation into astrocytes (GFAP+, green), neurons (Tuj-1+, red) and
oligodendrocytes (O4+, black). ac, anterior commissure; aq, aqueduct; cbl, cerebellum; cc, corpus callosum; ctx, cerebral cortex; DG, dentate gyrus; LV, lateral ventricle; ob, olfactory
bulb; str, striatum.
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respectively, as compared with neurospheres from littermate controls
by qRT-PCR (Fig. 2A). Using uncultured tissue, Bmi-1 transcript levels
were 8.5 to 11.1-fold higher in P0 ventricular zone and in the adult SVZ
of line B and Line C transgenic mice as compared to littermate controls
(Fig. 2A). At the protein level, using anti-HA antibody, wewere able to
detect the expression of the HA-tagged Bmi-1 in both cultured
neurospheres from adult SVZ and in freshly dissected E14.5 tele-
ncephalon tissue and P0 brain from lines B and C (Figs. 2B–D). Using
anti-Bmi-1 antibody, this translated to a signiﬁcant overall increase in
Bmi-1 expression by cultured neurospheres and uncultured telence-
phalon/P0 brain cells from transgenic mice (Figs. 2B–D). Furthermore,
immunohistochemical staining of Bmi-1 in tissue sections from E15
transgenic and control mouse telencephalon showed signiﬁcantlyFig. 2. Bmi-1 expression was elevated in transgenic neural stem/progenitor cells. (A) qRT
transgenic P0 VZ and adult SVZ cells as well as in neurospheres cultured from adult transgeni
from 3 to 5 independent experiments) relative to control cells, which were set to 1. Total c
Western blotting showed the expression of HA tag, as well as increased Bmi-1 and decreased p
Western blotting showed the expression of HA tag and increased Bmi-1 levels in E14.5 telen
p16Ink4a and p19Arf were not detected in E14.5 telencephalon (C) or P0 brain (D) from eit
staining of Bmi-1 on coronal sections of E15 wild type and line B transgenic telencephalon.increased Bmi-1 expression in most VZ cells in the transgenic mice
(Fig. 2E). Together, these data demonstrate that transgene expression
led to Bmi-1 over-expression in neural stem and progenitor cells in
vitro and in vivo throughout CNS development. Moreover, the level of
Bmi-1 expression within transgenic mice appeared similar or higher
than the level observed within human glioma specimens by both
immunohistochemistry (compare Fig. 2E to Suppl. Figs. 1A–F) and
western blot (Suppl. Fig. 1G).
To test whether the increase in Bmi-1 expression in transgenic
mice correlated with increased Bmi-1 function, we assessed the
expression of the Bmi-1 target genes Ink4a and Arf. The Bmi-1-
containing polycomb repressor complex 1 represses Ink4a and Arf
expression (Bracken et al., 2007; Bruggeman et al., 2005, 2007;
Molofsky et al., 2005). Cultured neurospheres from line B and line C-PCR showed that Bmi-1 transcript expression was markedly increased in uncultured
c SVZ cells as compared to littermate control cells. Fold change is presented (mean±s.d.
DNA levels in each pair of samples were normalized based on β-actin expression. (B)
16Ink4a and p19Arf in transgenic as compared to control neurospheres from lines B and C.
cephalon (C) and P0 brain (D) from transgenic as compared to control mice. Note that
her transgenic or control mice, as expected. (E) Representative immunohistochemical
Bmi-1 staining was nuclear, LV is lateral ventricle.
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to neurospheres cultured from littermate controls (Fig. 2B). This
demonstrated that transgenic Bmi-1 was functionally active and that
Bmi-1 over-expression attenuated the induction of p16Ink4a and p19Arf
that occurs in cultured cells. Consistent with earlier studies that failed
to detect p16Ink4a or p19Arf expression in fetal and young adult mouse
brain (Bruggeman et al., 2005, 2007; Molofsky et al., 2003, 2005;Fig. 3. Bmi-1 over-expression increased the self-renewal and neuronal differentiation of n
isolated SVZ cells from 2 to 3 month old transgenic mice gave rise to multipotent neurosphe
neurospheres formed per transgenic SVZ (from both brain hemispheres) was not signiﬁcan
neurospheres were signiﬁcantly larger than control neurospheres (C; ⁎, pb0.01) and gave
pb0.05). (E, F) Single CD15+CD24− SVZ cells from P5 wild type and transgenic mice we
were larger than controls (E; ⁎, pb0.01) and generated signiﬁcantlymoremultipotent second
stem cell colonies showed a signiﬁcantly higher frequency of BrdU+ cells as compared to con
were capable of multilineage differentiation and gave rise to larger numbers of neurons as
numbers of neurons (N100) as compared to control colonies (pb0.01 for line B and pb0.05Nishino et al., 2008) we were also unable to detect these proteins in
transgenic mice or littermate controls at E14.5 (Fig. 2C) or P0 (Fig. 2D).
The observation that over-expressed Bmi-1 was able to reduce
p16Ink4a and p19Arf expression in culture, but that p16Ink4a and
p19Arf expression could not be detected in vivo raised the possibility
that Bmi-1 over-expressionwould promote self-renewal/proliferation
to a greater degree in culture.eural stem/progenitor cells in culture. (A) A signiﬁcantly higher percentage of freshly
res than littermate control cells. (⁎, pb0.05); however, the total number of multipotent
tly different from control SVZ (B, p=0.31 for line B and p=0.55 for line C). Transgenic
rise to signiﬁcantly more multipotent secondary neurospheres upon subcloning (D; ⁎,
re sorted per well of 96 well plates. The transgenic single cell-derived neurospheres
ary neurospheres upon subcloning (F; ⁎, pb0.01). (G) Adherent Bmi-1 transgenic neural
trol colonies after a 1 hour pulse with BrdU (⁎, pb0.01). (H, I) Transgenic neurospheres
compared to control colonies. Signiﬁcantly more transgenic colonies contained large
for line C). Data represent mean±s.d. from 3 to 5 independent experiments.
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neurogenesis in culture
To assess the consequences of Bmi-1 over-expression we
compared the frequency of adult SVZ cells from transgenic and
control mice that formed multipotent neurospheres, the diameter of
these neurospheres, as well as their self-renewal potential. A
modestly (1.7-fold) but signiﬁcantly (pb0.05) higher percentage of
dissociated adult SVZ cells from line B and line C transgenic mice
formed multipotent neurospheres in culture (Fig. 3A). However,
when multiplied by the total number of dissociated SVZ cells
obtained from each mouse, this did not translate into a signiﬁcantFig. 4. Bmi-1 over-expression had little effect on fetal or adult neural stem/progenitor cell
between transgenic and control mice after a 2 hour pulse of BrdU (p=0.31 for line B and
Representative confocal images showing BrdU+ cell distribution in wild type and transge
distribution or frequency of BrdU+ cells were noted between wild type and transgenic emb
were found between transgenic and control embryos. Numbers in parenthesis indicate VZ tincrease in the total number of multipotent neurospheres per SVZ in
the transgenic mice (Fig. 3B). The slight increase in the frequency of
multipotent neurospheres could either reﬂect a slightly increased
frequency of stem cells in the SVZ of transgenic mice in vivo or
slightly increased survival of these cells in culture. The neurospheres
formed by transgenic cells were signiﬁcantly larger than the neuro-
spheres from littermate controls (Fig. 3C), demonstrating that
elevated Bmi-1 expression increased the proliferation of stem/
progenitor cells in culture. This is further supported by the
signiﬁcantly increased proliferation rate observed in adherently
cultured transgenic neural stem cell colonies based on BrdU
incorporation (Fig. 3G). To focus on the self-renewal potential ofproliferation in vivo. (A) The rate of BrdU incorporation by SVZ cells was comparable
p=0.08 for line C; data represent mean±s.d. from 4 independent experiments). (B)
nic E14.5 telencephalon after a 15 minute pulse of BrdU. No differences in the gross
ryos. (C) No differences in the thickness of the cerebral cortex or VZ (as indicated in B)
hickness as a fraction of total cortex thickness.
265S. He et al. / Developmental Biology 328 (2009) 257–272stem cells rather than the overall proliferation of the heterogeneous
progenitors that compose stem cell colonies, we dissociated and
subcloned individual primary neurospheres into secondary cultures
and counted the number of multipotent secondary neurospheres that
arose per primary neurosphere. Stem cells from line B and line C
transgenic mice exhibited dramatically increased self-renewal in
culture as compared to stem cells from littermate controls (Fig. 3D).
At the extraordinarily low cell densities used in our experiments
(approximately 1 cell/μl) control experiments indicated that most
neurospheres were clonally derived (Suppl. Fig. 5). Nonetheless, toFig. 5. Bmi-1 over-expression had little effect on fetal or adult neurogenesis. (A) One to two m
later, the frequency of BrdU+NeuN+ neurons in the olfactory bulbwas signiﬁcantly reduced am
mean±s.d. from 3 to 4 independent experiments). (B–F) Representative images from line C t
the frequencyand localization of Tuj1+neurons in the cerebral cortexwas similar between tran
thepostnatal transgenicmousebrain. Reelin labels Cajal–Retzius neurons in layer I of theneona
controls were pulsed with a single injection of CldU at E17 and analyzed at P20: no difference
(II–IV) neurons. (G) High magniﬁcation confocal images of the same tissue sections as shown
stained cells are yellow). The frequency of CldU+Cux-1+ neurons as compared to total CldU+conﬁrm that Bmi-1 increased the self-renewal of clonal neural stem
cell colonies we sorted individual CD15+CD24− SVZ cells from P5
wild type and transgenic mice into different wells of 96 well plates.
CD15+CD24− SVZ cells are enriched for neural stem cells (Capela and
Temple, 2002). Neurospheres arose in only 10–17% of wells seeded
with single CD15+CD24− cells. We found that transgenic neuro-
spheres were signiﬁcantly larger and had signiﬁcantly more self-
renewal potential than wild-type neurospheres (Figs. 3E, F). These
data demonstrate that elevated Bmi-1 expression increases the
proliferation and self-renewal of CNS stem cells in clonal culture.onth old transgenic and control mice were pulsed with BrdU for one week. Four weeks
ong line B transgenics (p=0.02) butwas not affected in line C (p=0.74; data represent
ransgenic mice show normal cortical neurogenesis in Bmi-1 transgenic mice. (B) At E12,
sgenic and control littermates. (C, D) Cortical layer organization appeared to be normal in
tal cortex (C) and FoxP2 labels layerVIneurons (D). (E, F) Bmi-1 transgenics and littermate
was observed in the frequency or localization of CldU+ neurons. Cux-1 labels upper layer
in (E, F). Cux-1 staining is shown in red while CldU staining is shown in green (double
cells (H) and as compared to total Cux-1+ neurons (I) was normal in transgenic mice.
266 S. He et al. / Developmental Biology 328 (2009) 257–272Loss of Bmi-1 reduces neuronal differentiation from CNS stem cells
in culture (Bruggeman et al., 2007; Zencak et al., 2005). To test
whether over-expression of Bmi-1 affects stem cell differentiation, we
differentiated primary neurospheres from both transgenic lines to
assess their ability to generate Tuj-1+ neurons, GFAP+ astrocytes and
O4+ oligodendrocytes in culture. The frequency of oligodendrocytes
was comparable in transgenic and wild type multipotent stem cell
colonies (Fig 3I; 0.5±0.6% of cells in wild type, 1.0±1.1% of cells in
line B transgenic and 1.1±1.0% in line C transgenic respectively).
However, transgenic stem cell colonies consistently contained an
increased proportion and absolute number of neurons as compared to
control colonies (3.9±4.9% in wild type, 23±18% in line B transgenic
and 31±17% in line C transgenic respectively) (Figs. 3H, I;).
Transgenic stem cell colonies also contained a modestly reduced
frequency of astrocytes as compared to wild-type colonies (95±4% in
wild type, 76±18% in line B transgenic and 67±17% in line C
transgenic respectively). Since multipotent transgenic colonies
contained many more cells than multipotent wild type colonies
(3700±2700 cells/wild type colony versus 21,000±17,000 cells/line
B colony and 10,000±8000 cells/line C colony after 10 days in
culture), the reduced frequency of astrocytes in transgenic colonies
reﬂected the dramatic increase in the number of neurons in these
colonies, rather than a decrease in the absolute number of astrocytesFig. 6. Bmi-1 over-expression had little effect on gliogenesis in vivo. (A–E)We did not detect
indicated by the normal number and distribution of MBP+ oligodendrocytes (A) and GFAP+ a
gliogenesis (C–E). (F, G) While no difference was observed in the frequency of GFAP+ astr
oligodendrocytes was transiently reduced as compared to littermate controls at P4 (G). As w
terms of the frequency of GFAP+ astrocytes or MBP+ oligodendrocytes (data not shown).per colony. Bmi-1 over-expression thus increased the neurogenic
capacity of CNS stem cells in culture.
Bmi-1 over-expression has little effect on neural stem/progenitor cell
proliferation in vivo
To evaluate the effects of Bmi-1 over-expression in vivo, we
compared various measures of stem/progenitor cell function between
control and Bmi-1 transgenic mice. We administered a pulse of BrdU
to 2–4 month old transgenic and littermate control mice two hours
before they were sacriﬁced to test whether Bmi-1 over-expression
increased the overall proliferation of neural stem and progenitor cells
in the SVZ. In contrast to the signiﬁcantly enhanced proliferation
exhibited by cultured transgenic neural stem/progenitor cells (Fig.
3G), neither line B nor line C transgenic mice showed a signiﬁcant
difference in the frequency of BrdU+ cells in the SVZ when compared
with littermate controls (Fig. 4A).
To test whether Bmi-1 over-expression could affect neural stem/
progenitor cell proliferation during fetal development, we adminis-
tered BrdU to timed pregnant females to mark dividing cells in the
developing telencephalon of wild type and transgenic embryos. After
a 15 minute BrdU pulse, many cells in the VZ of both wild type and
transgenic embryos became BrdU+, indicating rapid proliferation.any effect of Bmi-1 over-expression on postnatal gliogenesis in line C transgenic mice, as
strocytes (B) in the adult transgenic brain as well as the normal timing of early postnatal
ocytes in P4 line B wild type and transgenic mouse brains (F); the frequency of MBP+
ith line C, adult line B transgenic mice exhibited no difference relative to control mice in
Fig. 7. Bmi-1 over-expression increased proliferation, self-renewal, and neurogenesis by wild-type but not Ink4a-Arf deﬁcient neural stem/progenitor cells in culture. Wild type and
Ink4a-Arf deﬁcient neural stem cells were infected with either a Bmi1-encoding retrovirus (MSCV-Bmi1-IRES-GFP) or control retrovirus (MSCV-GFP). (A) qRT-PCR conﬁrmed a 4 to
5.5-fold increase in Bmi-1 expression in MSCV-Bmi-1 infected neurospheres as compared to neurospheres infected with control virus. (B) Wild type neurospheres infected with
MSCV-Bmi1 were signiﬁcantly larger than those infectedwith control virus or uninfected neurospheres (pb0.01). In contrast, MSCV-Bmi1 infection did not affect the size of Ink4a-Arf
deﬁcient neurospheres (p=0.57). Data represent mean±s.d. from 3 to 4 independent experiments. (C) Wild type neurospheres infected with MSCV-Bmi1 virus exhibited
signiﬁcantly increased self-renewal as compared to neurospheres infected with control virus or uninfected neurospheres (pb0.05). In contrast, MSCV-Bmi1 infection did not affect
the self-renewal of Ink4a-Arf deﬁcient neurospheres (p=0.45). Data represent mean±s.d. for 3–5 independent experiments. (D) MSCV-Bmi1 infection increased neuronal
differentiation within wild-type (⁎, pb0.05 relative to WT no virus) but not Ink4a-Arf deﬁcient neural stem cell colonies. Data represent mean±s.d. from 3 to 4 independent
experiments. (E–I) Bmi-1 transgenic mice (Bmi-1TG+) were also mated with Ink4a-Arf deﬁcient mice. (E) Freshly dissociated SVZ cells showed that Bmi-1TG+Ink4a-Arf−/− mice
expressed the transgene in vivo (green ﬁlled histogram), while Ink4a-Arf−/−mice (black open histogram) did not. (F). qRT-PCR analysis showed that Bmi-1 expressionwas increased
in the SVZ of Bmi-1TG+Ink4a-Arf−/−mice. (G) The frequency of multipotent neurospheres that arose in culture from Bmi-1TG+Ink4a-Arf−/− SVZ cells was not signiﬁcantly different
from Ink4a-Arf−/− SVZ. H,I). Bmi-1TG+Ink4a-Arf−/− neurospheres did not show increased diameter or self-renewal potential as compared with Ink4a-Arf−/− neurospheres.
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269S. He et al. / Developmental Biology 328 (2009) 257–272However, we did not observe any difference in the distribution or
frequency of BrdU+ cells between transgenic and control embryos
(Fig. 4B). In addition, the overall thickness of the cerebral cortex and
the VZ did not signiﬁcantly differ between transgenic and wild-type
telencephalon (Fig. 4C). These data suggest that Bmi-1 over-expres-
sion does not cause a notable increase in proliferation within the
telencephalon during fetal development.
Bmi-1 over-expression has little effect on fetal or adult neurogenesis
in vivo
To assess whether Bmi-1 over-expression affected the rate of
olfactory bulb neurogenesis in vivo, we administered BrdU to 1–
2 month old transgenic and littermate control mice for one week to
mark dividing SVZ progenitors followed by a one month chase
without BrdU to allow these cells to migrate into the olfactory bulb
and to differentiate into neurons. We then quantiﬁed the percentage
of NeuN+ neurons that were also BrdU+ by confocal microscopy.
Twenty-ﬁve random ﬁelds of view spanning the whole thickness of
the olfactory bulb were imaged and counted. Transgenic mice did not
exhibit an increased rate of neurogenesis as compared to littermate
controls (Fig. 5A). Indeed, line B transgenic mice exhibited a
signiﬁcantly lower rate of neurogenesis than littermate controls
because a subset (approximately 25%) of these mice were found to be
in the process of developing hydrocephalus when sacriﬁced, and the
mice with hydrocephalus tended to have reduced SVZ proliferation
and olfactory bulb neurogenesis (data not shown). Thus we could ﬁnd
no evidence of increased SVZ proliferation or neurogenesis in adult
transgenic mice in vivo, in contrast to what we had observed in
culture.
To test whether Bmi-1 over-expression could affect neurogenesis
during fetal CNS development, we examined the onset of cortical
neurogenesis as well as the organization of the cerebral cortex in the
forebrain of transgenic and control mice.Most cortical neurogenesis in
mice occurs from E10 to E17, when ventricular zone progenitors give
rise to waves of neuronal precursors that migrate toward the pial
surface, forming six distinct cortical layers. To examinewhether Bmi-1
over-expression affected the onset of cortical neurogenesis, we
stained E12 telencephalon with antibody against Tuj1 to label the
early born Cajal–Retzius neurons within the marginal zone (Hatten,
1999). We did not observe any difference between transgenic or
control mice in terms of the density or localization of these Tuj-1+
cells (Fig. 5B). This suggests that Bmi-1 over-expression did not
signiﬁcantly delay the onset of cortical neurogenesis.
Next we asked whether the overall organization of the cerebral
cortex in transgenic mice was altered by Bmi-1 over-expression. We
cut sections through the cerebral cortex of P0 or adult wild type and
transgenic mice and stained with the layer speciﬁc neuronal markers
Reelin (staining Cajal–Retzius neurons in layer I; (Soriano and Del Rio,
2005)), Cux-1 (staining layer 2–4 neurons; (Nieto et al., 2004)), and
FoxP2 (staining layer 6 neurons in the adult brain; (Ferland et al.,
2003)). In no case did we detect any difference between transgenic
mice and littermate controls in the frequency or localization of Reelin+
neurons at P0 (Fig. 5C), FoxP2+ neurons in adults (Fig. 5D), or Cux-1+
neurons at P20 (Fig. 5F). This suggests that cortical neuronal
progenitors acquire normal identities and a normal laminar fate
despite Bmi-1 over-expression.
To assess whether neurons were born according to a normal
schedule we pulse labeled wild type and transgenic embryos with theFig. 8. Aminority of Bmi-1 transgenic mice developed idiopathic hydrocephalus but showed n
brain sections showed enlarged lateral ventricles (LV) in the transgenic brain but a normal la
mice: lateral ventricles were enlarged, while the third and fourth ventricles as well as the sy
lateral and third ventricles in H&E stained serial brain sections. (D) The ependymal cell layer
over-expressing mice did not develop brain tumors, even when aged for approximately two
histology. Mice that did not develop hydrocephalus showed no sign of premature death relnucleotide analog 5-chloro-2-deoxyuridine (CldU) at E17 (a stage
when upper layer neurons are generated (Polleux et al., 1997)), and
stained sections cut at P20 with antibodies against CldU and Cux-1.
The CldU staining was concentrated in upper cortical layers as
expected (Figs. 5E, F) and there was a similar degree of CldU/Cux-1
co-localization in both wild-type and transgenic mice (Figs. 5G–I).
Therefore, we did not detect any signiﬁcant change in the timing or
pattern of cortical neurogenesis in the transgenic mouse brain,
suggesting that Bmi-1 over-expression did not signiﬁcantly alter
neurogenesis in vivo, though we cannot rule out the possibility of
subtle changes.
Bmi-1 over-expression has little effect on glial differentiation in vivo
While we did not observe signiﬁcant effects of Bmi-1 over-
expression on SVZ proliferation or neurogenesis in embryonic or
adult mice, we wondered whether Bmi-1 over-expression affected
gliogenesis since a loss of Bmi-1 leads to an increase in astrocytes in
vivo (Zencak et al., 2005). To test this we ﬁrst examined the
expression of the astrocyte marker GFAP and the oligodendrocyte
markerMBP in adult mice.We did not observe any difference between
line B or line C transgenic mice and littermate controls in the numbers
or positions of GFAP+ cells or MBP+ cells in the corpus callosum or
striatum (Figs. 6A,B). While this suggested that transgenic mice did
not have gross changes in gliogenesis, we also examined P4–P5 mice
to assess whether there were any early changes. We did not observe
any difference between line B or line C transgenic mice and littermate
controls in the numbers or positions of BFABP+ glia at P5 (Fig. 6E). We
also did not observe any differences among line C transgenic mice and
littermate controls in terms of the numbers or positions of GFAP+
astrocytes in the corpus callosum or MBP+ oligodendrocytes in the
corpus callosum and striatum at P5 (Figs. 6C, D). However, we did
observe a delay in oligodendrogliogenesis in line B transgenic mice,
which had fewer MBP+ oligodendrocytes as compared to littermate
controls in the P4 corpus callosum and striatumwhile the frequency of
GFAP+ astrocytes was relatively normal (Figs. 6F, G). The fact that this
delay was not observed in line C mice suggests that it may not be
attributable to increased Bmi-1 expression; however, we cannot rule
out the possibility that increased Bmi-1 expression delays glial
differentiation in some mice under certain circumstances. Overall,
our data suggest that elevated Bmi-1 expression has little effect on
gliogenesis in vivo.
Bmi-1 over-expression does not further enhance the self-renewal or
neurogenic potential of cultured Ink4a-Arf−/− neural stem cells
The increased overall proliferation, stem cell self-renewal, and
neurogenesis that occurred upon Bmi-1 over-expression in vitro (Fig.
3) but not in vivo (Figs. 4–6) correlated with the ability of over-
expressed Bmi-1 to reduce p16Ink4a and p19Arf expression in vitro but
not in vivo (Fig. 2). To test whether the effects of Bmi-1 over-
expression on neural stem cell function in culture were mediated by
its ability to oppose the induction of p16Ink4a and p19Arf expression in
culture, we over-expressed Bmi-1 in neural stem cells cultured from
newborn (P2–P6) wild-type and Ink4a-Arf deﬁcient mice. This was
done using a bicistronic retrovirus (MSCV-Bmi1) expressing both
mouse Bmi-1 and GFP. Adherently plated newborn lateral ventricle
germinal zone cells from wild type or Ink4a-Arf−/− mice were
infected with this virus or a control retrovirus bearing only GFPo sign of brain tumors. (A) Representative nissl stains of P5 line C and littermate control
minar organization of the cortex. (B) MRI images showed hydrocephalus in adult line C
lvius aqueduct were relatively normal. (C) No physical block was detected between the
(S100β+ cells) in the transgenic mouse brainwas abnormally folded in places. (E) Bmi-1
years. Brains in the “gross examination” column are in addition to those examined by
ative to control mice.
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neurospheres. Infected cells could thus be distinguished from non-
infected cells based on GFP expression. qRT-PCR indicated that Bmi-1
expression was increased by MSCV-Bmi1 infection as compared to
neurospheres that were infected with the control virus (Fig. 7A).
To assess overall proliferation and stem cell self-renewal we
measured the diameter of neurospheres and the capacity of multi-
potent neurospheres to form secondary multipotent neurospheres
upon subcloning, respectively. Wild type neurospheres infected with
MSCV-Bmi1 virus were signiﬁcantly larger than neurospheres
infected with MSCV-GFP control virus or uninfected neurospheres
(Fig. 7B), which is consistent with what we observed in Bmi-1
transgenic cells (Fig. 3C). In contrast, Ink4a-Arf−/− neurospheres were
signiﬁcantly larger than wild type neurospheres but over-expression
of Bmi-1 in Ink4a-Arf−/− neurospheres did not further increase their
size (Fig. 7B). Similar results were observed in the self-renewal assay.
While MSCV-Bmi1 infected wild type neurospheres generated
signiﬁcantly more multipotent secondary neurospheres as compared
to uninfected neurospheres or neurospheres infected with control
virus (Fig. 7C), over-expression of Bmi-1 in Ink4a-Arf−/− neuro-
spheres did not further enhance their self-renewal potential (Fig. 7C).
Finally, Bmi-1 over-expression or Ink4a-Arf deﬁciency each increased
the amount of neuronal differentiation observed in neural stem cell
colonies; however, over-expression of Bmi-1 in Ink4a-Arf deﬁcient
neural stem cells did not signiﬁcantly further increase neuronal
differentiation beyond what was observed with Ink4a-Arf deﬁciency
alone (Fig. 7D).
A similar experiment was performed using freshly isolated SVZ
cells from adult Bmi-1 transgenic mice crossed onto an Ink4a-Arf
deﬁcient background. Consistent with the data from retroviral Bmi-1
over-expression, transgenic Bmi-1 over-expression in Ink4a-Arf deﬁ-
cient mice no longer increased the frequency of multipotent neuro-
spheres, neurosphere diameter, or self-renewal potential (Figs. 7G–I).
Our data suggest that the increased proliferation, self-renewal, and
neuronal differentiation of cultured neural stem cells upon Bmi-1
over-expression are largely attributable to the repressive effects of
Bmi-1 on p16Ink4a and p19Arf expression.
A subset of Bmi-1 transgenic mice developed hydrocephalus but not
CNS tumors
Bmi-1 transgenic mice from lines B and C were born at Mendelian
frequencies (Suppl. Fig. 4A). The mice had a normal appearance at
birth and no behavioral abnormalities were noted; however, the
transgenic mice consistently exhibited enlarged lateral ventricles
(Fig. 8A). We cut sections throughout lateral ventricles to look for
blockages that could prevent the ﬂow of cerebrospinal ﬂuid out of
the lateral ventricles but never detected any blockage. Thus it is
unclear why Bmi-1 transgenic mice were born with enlarged lateral
ventricles.
Between 4 and 8 weeks of age, a minority of transgenic mice from
both transgenic lines (7 of 28 (25%) mice from line B and 14 of 61
(23%) mice from line C) developed hydrocephalus. The mice with
hydrocephalus could be distinguished based on the dome shaped
appearance of their heads, severely enlarged lateral ventricles, and
behavioral changes that included weight loss, lethargy, and rufﬂed fur.
Hydrocephalus was conﬁrmed in these mice by magnetic resonance
imaging (MRI) (Fig. 8B). MRI images showed that lateral ventricles
were most affected in these mice; the third ventricle, sylvius
aqueduct, and fourth ventricle appeared relatively normal (Fig. 8B).
However, we could not ﬁnd any obstruction between the lateral and
third ventricles nor any blockage within the third ventricle or the
aqueduct that would explain the hydrocephalus phenotype (Fig. 8C).
Nonetheless, it remains possible that a physical blockage exists in the
ventricular system in vivo that is not readily detected by histology or
MRI.We also assessed other common causes for mouse hydrocephalus
such as over-proliferation of choroid plexus, or defects in the
ependyma lining the lateral ventricle. No abnormal mass of choroid
plexus was observed in the transgenic mice (data not shown). Some
transgenic mice with hydrocephalus did exhibit an abnormally
folded ependymal cell lining of the lateral ventricle (Fig. 8D), a
similar phenotype was observed in transgenic mice that never
developed hydrocephalus. Thus it was unclear whether the ependy-
mal layer abnormality contributed to the development of hydro-
cephalus. The ependymal cells in young adult mice did not
incorporate a two-hour pulse of BrdU (data not shown), so they
were not proliferating rapidly as would be expected if these cells
were neoplastic. Finally, we also tested whether hydrocephalus was
associated with cortical atrophy due to increased apoptosis in the
cerebral cortex. However, sections from hydrocephalic transgenic
mouse brains did not exhibit increased activated caspase-3 staining
relative to littermate controls and little apoptosis was observed in
either the control or transgenic brains (data not shown). Overall, we
detected no evidence of lateral ventricle malformations or blockages
that could explain why hydrocephalus developed and we never
detected any tumors in the brains of these mice by either histology
or MRI.
The 75% of transgenic mice that were not affected by hydro-
cephalus remained healthy and we never detected any abnormalities
in appearance or behavior. Line C mice had normal body mass and
brain mass while line B mice had slightly but signiﬁcantly increased
brain mass and slightly but signiﬁcantly decreased body mass by
young adulthood (Suppl. Figs. 4B, C). We aged these mice for up to
25 months and detected no evidence of premature death or illness
as compared to control littermates. To look for evidence of CNS
tumors in the transgenic mice, we sacriﬁced newborn (3 line B and
4 line C), 1–4 month old (5 line B and 16 line C) and 15–24 month
old (2 line B and 3 line C) transgenic mice and analyzed serial
sections of the whole brain by histology (Fig. 8E). We also grossly
examined the brains from all of the transgenic mice used in earlier
experiments (more than 50 mice from each line). We detected no
evidence of brain tumors in any mouse at any age (Fig. 8E). Some
transgenic and wild type mice spontaneously developed non-neural
neoplasms (mostly hematopoietic) after being aged for more than
20 months; however, none of these neoplasms contained GFP-
expressing cells, suggesting that transgene expression did not
contribute.
Immunohistochemical staining of Bmi-1 in sections (compare Fig.
2E to Suppl. Figs. 1A–F) and Bmi-1 western blot (Suppl. Fig. 1G)
suggest that the level of Bmi-1 expression in the transgenic mouse
brain is comparable to the level of expression observed in brain
tumors, at least in the fetal telencephalon. However, we have been
unable to examine levels of Bmi-1 protein expression in the SVZ of
adult transgenic mice because the adult SVZ yielded insufﬁcient
material for western blot, and high background staining of the adult
SVZ by immunohistochemistry (the anti-Bmi-1 antibody was made in
mouse) made this difﬁcult to interpret. Nonetheless, Bmi-1 transcript
levels were elevated in the transgenic adult SVZ by 8.5 to 11-fold
relative to control SVZ (Fig. 2A). As a result, available data suggest that
Bmi-1 expression levels in CNS stem/progenitor cells from transgenic
mice were comparable to those observed within brain tumors, but we
cannot rule out the possibility that further increases in expression
within adult CNS cells might render these cells tumorigenic. None-
theless, it is not clear whether it is possible to achieve further
increases in expression as all transgenic mice with higher transgene
copy numbers silenced the transgene. Since prior studies have
suggested that Bmi-1 is degraded when unable to bind other
polycomb repressor complex 1 components (Ben-Saadon et al.,
2006; Hernandez-Munoz et al., 2005), the stoichiometry of other
complex components may limit the degree towhich Bmi-1 expression
and function can be increased.
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In this study, we generated Nestin-Bmi-1-GFP transgenic mice to
study the effect of Bmi-1 over-expression in neural stem/progenitor
cells on CNS development and tumorigenesis. Bmi-1 over-expression
in CNS stem/progenitor cells in vitro was sufﬁcient to signiﬁcantly
increase stem cell self-renewal, overall proliferation, and neuronal
differentiation (Fig. 3). In contrast, Bmi-1 over-expression in vivo had
little effect on SVZ proliferation, adult olfactory bulb neurogenesis, or
neurogenesis/gliogenesis during development (Figs. 4–6). Bmi-1
transgenic mice showed only a mild increase in neural stem cell
frequency (b2-fold; Fig. 3A) with no increase in the total number of
neural stem cells per mouse (Fig. 3B). They also exhibited no
evidence of tumorigenesis, even when aged for more than 20 months
(Fig. 8E). These data demonstrate that Bmi-1 over-expression has
much more profound effects on CNS stem cell function in culture
than in vivo.
The increased effect of Bmi-1 over-expression in culture correlated
with its ability to reduce p16Ink4a and p19Arf expression in culture.
Although p16Ink4a and p19Arf are not detectably expressed by neural
stem/progenitor cells in developing or young adult mice (Bruggeman
et al., 2005, 2007; Molofsky et al., 2003, 2005; Nishino et al., 2008)
(Figs. 2C, D), p16Ink4a and p19Arf are induced in culture in neural stem
cells (Molofsky et al., 2003) in response to the stress associated with
adaptation to the unphysiological culture environment (Lowe and
Sherr, 2003; Sherr and DePinho, 2000). Since p16Ink4a and p19Arf were
not detectably expressed by neural stem/progenitors cells in vivo,
Bmi-1 over-expression had no effect on p16Ink4a and p19Arf expression
in vivo. In contrast, Bmi-1 over-expression did reduce p16Ink4a and
p19Arf expression in culture (Fig. 2B). This suggested that the
increased effects of Bmi-1 over-expression in culture were caused
by its ability to reduce p16Ink4a and p19Arf expression in culture.
Consistent with this, Bmi-1 over-expression no longer enhanced self-
renewal, proliferation, or neurogenesis in Ink4a-Arf deﬁcient neural
stem cells in culture (Fig. 7). These data demonstrate that caution
must be exercised when inferring in vivo functions for Bmi-1 based
on observations collected in culture because the increased expression
of p16Ink4a and p19Arf in culture increases the reliance of cells upon
Bmi-1 and makes cells respond to Bmi-1 over-expression in a way
that is not observed in vivo.
In Bmi-1 deﬁcient mice in vivo, neural stem cells require Bmi-1
postnatally, but not during fetal development, for self-renewal. Fetal
Bmi-1 deﬁcient mice do not exhibit detectable p16Ink4a and p19Arf
expression in neural tissue in vivo and are born with normal numbers
of neural stem cells (Molofsky et al., 2003). In contrast, postnatal Bmi-
1 deﬁcient mice exhibit elevated p16Ink4a and p19Arf expression in
neural tissues in vivo and neural stem cells become increasingly
depleted with time (Molofsky et al., 2003). This depletion of neural
stem cells can be largely, but not completely, rescued by Ink4a and/or
Arf deﬁciency (Bruggeman et al., 2005; Molofsky et al., 2005, 2003).
These data suggest that the primary physiological role for Bmi-1 in the
nervous system is to repress Ink4a-Arf in postnatal stem cells and to
promote the maintenance of these cells throughout adulthood
(Bruggeman et al., 2005; Molofsky et al., 2003, 2005). Nonetheless,
a recent study found that shRNA knockdown of Bmi-1, primarily in
cultured fetal neural stem cells, resulted in a self-renewal defect
(Fasano et al., 2007). These authors speculated that acute knockdown
of Bmi-1 revealed a physiological role for Bmi-1 in fetal neural stem
cells that was not evident in germline knockout mice. One possibility
is that unknown mechanisms in germline Bmi-1 knockout mice
compensate for the loss of Bmi-1 during fetal development. Another
possibility is that shRNA knockdown of Bmi-1 in cultured fetal neural
stem cells reﬂected a function for Bmi-1 that is not required in vivo
because these cells express p16Ink4a and p19Arf in culture in a way that
does not occur in vivo. To distinguish between these possibilities it
will be necessary to study Bmi-1ﬂoxed mice to determine whetherconditional deletion of Bmi-1 in vivo leads to neurodevelopmental
defects during fetal development.
Consistent with other recent studies (Bruggeman et al., 2007;
Leung et al., 2004), we observed elevated levels of Bmi-1 expression in
many brain tumors as compared to normal brain tissue, irrespective of
whether the tumors were low or high grade (Suppl. Fig. 1). Indeed,
Bmi-1 is required for the growth of gliomas and for glioma stem cell
function, through Ink4a-Arf dependent and independent mechanisms
(Bruggeman et al., 2007). However, our data demonstrate that the
degree of Bmi-1 over-expression that can be achieved in transgenic
mice does not promote tumorigenesis in the CNS. Thus, increased
Bmi-1 expression is not likely to be an initiating event in the formation
of brain tumors. Rather, Bmi-1 may be required to cooperate with
other mutations, such as to reduce the extent to which oncogenic
stimuli induce p16Ink4a and p19Arf expression. In medulloblastomas,
elevated Bmi-1 expression may reﬂect mutations that activate sonic
hedgehog signaling (Leung et al., 2004). Elevated Bmi-1 expression in
brain tumors may be the consequence of other mutations, or may
confer a selective advantage in the context of mutations, but is not
likely to reﬂect a primary role for increased Bmi-1 expression in the
initiation of tumorigenesis.Acknowledgments
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